Besides treatment for DRE, ATN-DBS has been utilized to control refractory and super-refractory status epilepticus (Lee et al., 2017; Imbach et al., 2019; Yuan et al., 2019; Sobstyl et al., 2020). This evidence concerns the gene TYR and status epilepticus.